Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

Notice of Correction to Award Information and Application and Submission Information for PA-27-037 "Predoctoral to Postdoctoral Transition Award (Parent F99/K00 - Clinical Trial Not Allowed)"

Active
NOT-OD-26-091Grant

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

This notice provides corrections to the award and application information for the Predoctoral to Postdoctoral Transition Award (Parent F99/K00), specifically for solicitation NOT-OD-26-091 issued by the National Institutes of Health. The primary updates involve the removal of Kirschstein-NRSA support period limitations. Eligible individuals may now receive up to five years of aggregate support, consisting of up to two years at the F99 predoctoral level and up to three years at the K00 postdoctoral level. Additionally, the notice clarifies that a Certification Letter is no longer required for these applications, and corresponding instructions have been removed from the SF424(R&R) Other Project Information section. These changes are effective for the application due date of August 8, 2026. For further inquiries, the Division of Biomedical Research Workforce serves as the primary point of contact.

General Info

NIH updates F99/K00 awards: extended support periods and no Certification Letter required.

Documents

0

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

Posted

Contract opportunity posted

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyNational Institutes Of Health Office Of The Director
Contacts1 person available
OfficeUSA
Office AddressUSA
Contacts
Division of Biomedical Research Workforce (DBRW

Full Description

Show more
The purpose of this notice is to correct the Award Information and Application and Submission Information for PA-27-037, Predoctoral to Postdoctoral Transition Award (Parent F99/K00 - Clinical Trial Not Allowed). In Section II, the Award Project Period and Stipends guidance has been revised to remove Kirschstein-NRSA support period limitations and related language. Specifically:/pulliiAward Project Period has been revised to state: "Individuals may receive up to five years of aggregate support across both phases, including up to two years at the F99 predoctoral level and up to three years at the K00 postdoctoral level."/liliiStipends information has been revised to remove "Kirschstein-NRSA" from the first sentence./ulpIn addition, this notice clarifies that a Certification Letter is not required for this application. Accordingly, the Certification Letter instructions have been removed from the SF424(R&R) Other Project Information instructions in Section IV./ppThis notice is effective for the August 8, 2026 due date.

Similar Contracts

Same NAICS industry code

NAICS: 541715
New
Federal
U.S. Army Contracting Command – Watervliet Arsenal (ACC-WVA) Organic Industrial Base (OIB) Modernization Commercial Solutions Opening (CSO)
Solicitation # W911PT26SC001
The U.S. Army Contracting Command – Watervliet Arsenal (ACC-WVA) has issued solicitation W911PT26SC001, a Commercial Solutions Opening (CSO) authorized under the National Defense Authorization Act for Fiscal Year 2026 and DFARS Subpart 212.70. This competitive solicitation is open until September 30, 2027, and is designed to acquire innovative commercial products, technologies, and services to modernize the Army's Organic Industrial Base. The scope focuses on integrating manufacturing resources, linking legacy analogue systems with digital systems, and expanding modeling and simulation to enhance the delivery of materiel solutions. The CSO targets both traditional and non-traditional business entities, including small businesses and foreign-owned firms, provided they maintain an active System for Award Management (SAM) profile and a Unique Entity ID. The acquisition process follows a multi-phased approach consisting of a written solution brief, an optional presentation or pitch, and a final Request for Commercial Solution Proposal (CSP). Evaluation is based on responsiveness, technical merit, uniqueness, and price reasonableness. Successful responses may result in fixed-price contracts awarded under FAR Part 12 Commercial Item Procedures. Current Areas of Interest (AoIs) include advanced cannon technology, electrical infrastructure improvements at Building 120, chromium facility conversion, automated manufacturing for minor components, automated cooling tower treatments, advanced CNC vertical turning lathes, and advanced tooling for radial forging. Performance is primarily located at Watervliet Arsenal and Benet Laboratories, with a general period of performance not to exceed 12 months unless otherwise specified.
W6QK Acc Wva

POSTED

about 9 hours ago

DEADLINE

in 11 months
View Details

More opportunities from National Institutes Of Health Office Of The Director

Same awarding agency

NAICS: 541714
Grant
Limited Competition: NIH Research Evaluation and Commercialization Hubs (REACH) (SB0 Clinical Trial Optional)
Solicitation # RFA-OD-27-009
The National Institutes of Health Office of the Director is offering a limited competition funding opportunity under solicitation RFA-OD-27-009 to renew the Research Evaluation and Commercialization Hub (REACH) program. This initiative aims to accelerate the translation of academic biomedical discoveries into tangible products that enhance public health and patient care by funding the creation of academic entrepreneurship Hubs. These Hubs will provide innovators with essential seed investment, mentorship in product development, and resources for proof-of-concept work to advance high priority technologies aligned with the NIH mission. Selected Hubs will operate as a consortium to establish infrastructure for identifying promising technologies and provide funding for product definition studies, such as prototype development and feasibility research. They will also offer expertise in regulatory, business, legal, and project management areas while fostering skills in entrepreneurship. Success in this program relies heavily on the establishment of public-private partnerships and the acquisition of non-federal funding. Eligible organizations must submit their applications by November 11, 2026, and will undergo a standard peer-review process to determine merit for funding.
Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

27 days ago

DEADLINE

in 21 days
View Details

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS